Etid klinik pou Obèsite nan Connecticut
22 etid pou Obèsite ap chèche patisipan nan sit nan Connecticut.
Vil nan Connecticut
Tèks ofisyèl etid la (Anglè)
Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles
- University of Connecticut, Storrs
Ap rekriteVolontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 28, 2026 · NCT07844616A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Yale School of Medicine - Yale Diabetes Center (YDC)) Trials, New Haven
- Stamford Therapeutics Consortium, Stamford
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- New England Research Associates, LLC, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- New England Research Associates, LLC, Bridgeport
- Yale University School of Medicine, New Haven
- Chase Medical Research, LLC, Waterbury
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Chase Medical Research, LLC, Waterbury
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Cardiology Associates of Fairfield County PC, Stamford
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Yale University, New Haven
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Waterbury
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Stamford Therapeutics Consortium, Stamford
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Stamford
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Chase Medical Research LLC, Waterbury
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Bridgeport
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284875Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Hamden
- Kailera Clinical Site, Stamford
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07284979AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Chase Medical Research LLC, Waterbury
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07509307A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
- UConn Health, Farmington
- Hartford HealthCare, Hartford
- University of Connecticut, Storrs
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Aug 12, 2026 · NCT07238556Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
- Hartford HealthCare, Hartford
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Aug 6, 2026 · NCT06484621Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
- Yale Pediatric Diabetes Center, Adult and Children's Progam, New Haven
Ap rekriteFaz 2
Laj 18 a 30 · Tout sèks · Mizajou Aug 4, 2026 · NCT06411210A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Chase Medical Research LLC, Hamden
- Chase Medical Research LLC, Waterbury
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07481630Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
- Yale University, New Haven
Ap rekriteVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT07376655New Mechanisms of Obesity
- Yale University, New Haven
Ap rekrite
Laj 15 a 22 · Tout sèks · Mizajou Jan 28, 2026 · NCT06768827Craving Network Neurofeedback
- Yale MRRC Anlyan Center, New Haven
Ap rekriteVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Dec 3, 2025 · NCT06426693Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.